innat
immun
system
fig
innat
immun
respons
mediat
phagocyt
cell
neutrophil
macrophag
fulli
develop
late
gestat
declin
function
capac
gestat
approach
increas
fetal
cortisol
level
humor
element
complement
present
howev
level
adult
interferon
induc
fetu
earli
day
gestat
cellular
compon
acquir
immun
respons
present
fetal
calv
number
peripher
blood
cell
dramat
decreas
begin
month
birth
traffic
popul
lymphoid
tissu
fetal
calv
decreas
approxim
birth
b
cell
present
much
lower
number
develop
fetus
matur
calv
hallmark
bovin
fetus
agammaglobulinemia
almost
antibodi
unless
infect
utero
even
rel
low
level
compar
adult
compris
predominantli
igm
immunolog
respons
fetu
antigen
pathogen
increas
stage
fetal
develop
case
bovin
viral
diarrhea
viru
bvdv
infect
fetus
infect
bvdv
day
gestat
lead
immunolog
toler
calv
becom
persist
infect
bvdv
persist
infect
calv
never
mount
protect
respons
infect
fetal
lymphocyt
respons
mitogen
day
gestat
day
fetus
develop
antibodi
parainfluenza
bvdv
day
although
fetus
respond
immunolog
pathogen
congenit
infect
bvdv
eg
last
half
one
third
gestat
result
neg
health
reproduct
consequ
young
calv
heifer
effect
includ
twofold
increas
sever
ill
diarrhea
pneumonia
young
calv
delay
onset
estru
accur
method
assess
immunolog
reproduct
damag
congenit
bvdv
infect
one
exercis
caution
consid
retain
normal
heifer
born
herd
exhibit
clinic
problem
result
bvdv
reproduct
diseas
ie
abort
persist
infect
weak
calv
newborn
calv
immunolog
birth
chanc
enhanc
adapt
immun
experi
protect
environ
womb
also
limit
activ
phagocyt
entri
tissu
calv
handicap
matern
factor
hormon
influenc
parturit
lack
antibodi
circul
tissu
ingest
colostrum
essenti
provid
neonat
immunolog
protect
least
first
week
life
fig
colostrum
compos
primarili
antibodi
cytokin
cell
antibodi
critic
compon
colostrum
provid
immedi
sourc
antibodi
agammaglobulinem
calv
calv
ingest
colostrum
shortli
birth
signific
concentr
immunoglobulin
serum
wherea
colostrumdepriv
calv
trace
amount
immunoglobulin
first
day
life
endogen
product
igm
colostrumdepriv
calv
begin
appear
circul
day
birth
reach
function
level
mgml
day
age
level
circul
iga
igg
igg
reach
appreci
level
calv
day
birth
level
antibodi
approach
adult
level
approxim
month
birth
time
igg
half
adult
level
indic
strong
thelper
cell
bia
second
famili
compon
colostrum
includ
cytokin
immunolog
hormon
help
develop
fetal
immun
respons
clear
cytokin
secret
mammari
gland
produc
leukocyt
found
colostrum
interleukin
tumor
necrosi
factorbeta
interferongamma
present
bovin
colostrum
associ
proinflammatori
respons
may
help
recruit
neonat
lymphocyt
gut
aid
normal
immun
develop
colostrum
rapidli
improv
abil
neutrophil
phagocyt
bacteria
primarili
accomplish
absorpt
small
molecul
cytokin
work
pig
demonstr
colostr
cytokin
absorb
detect
blood
level
cytokin
peak
day
postpartum
high
level
two
antiinflammatori
cytokin
transform
growth
factor
suppress
local
secret
proinflammatori
cytokin
intestin
allow
gut
microbi
colon
third
famili
compon
colostrum
includ
cell
colostrum
contain
cellsmldalmost
exclus
leukocyt
viabl
leukocyt
present
percentag
similar
peripher
blood
larger
fraction
macrophag
smaller
fraction
lymphocyt
neutrophil
lymphocyt
lymphocyt
less
b
lymphocyt
matern
cell
enter
circul
reach
peak
level
hour
birth
anim
receiv
colostrum
contain
matern
leukocyt
develop
antigenpres
cell
faster
import
antigenpres
cell
keyston
cell
develop
acquir
immun
respons
pathogen
vaccin
pathogenspecif
matern
lymphocyt
vaccin
cow
isol
neonat
calv
maximum
induc
prolifer
day
birth
exact
role
cell
longterm
develop
pathogenspecif
acquir
immun
clear
longer
detect
circul
day
age
normal
fullterm
neonat
calv
colostr
absorpt
accomplish
intestin
cell
neonat
receptor
fcrn
endocytosi
use
transport
vacuol
absorpt
capac
begin
decreas
hour
birth
end
hour
neonat
corticosteroid
level
must
high
increas
colostr
absorpt
cold
stress
prematur
birth
cesarean
section
dystocia
inhibit
neonat
cortisol
releas
decreas
colostr
absorpt
administr
corticosteroid
prematur
newborn
calv
may
enhanc
surviv
although
essenti
immun
compon
present
neonat
birth
mani
compon
function
calv
least
week
age
may
continu
develop
puberti
develop
newborn
calv
subject
sever
immunomodulatori
effect
fig
placenta
produc
progesteron
prostaglandin
cytokin
eg
affect
nearterm
fetu
dam
suppress
cellmedi
memori
respons
contrast
mediat
promot
respons
antibodi
product
cow
also
produc
estrogen
cortisol
parturit
immunosuppress
effect
final
part
parturit
process
calv
produc
high
level
cortisol
remain
elev
first
week
life
cumul
effect
hormon
suppress
immun
respons
direct
immun
respons
away
respons
hormon
also
promot
shortterm
immun
respons
particularli
product
igm
box
placenta
estrogen
cortisol
pg
progesteron
decreas
acquir
immun
mechan
decreas
lymphocyt
respons
neonat
respons
antibodi
memori
ymajor
histocompat
complex
ii
yantigen
present
cell
born
memori
b
cell
antibodi
product
bcell
differenti
agammaglobulinem
must
obtain
antibodi
mother
colostrum
humor
compon
innat
system
present
limit
quantiti
function
well
adult
box
complement
activ
newborn
calv
birth
approxim
adult
cow
circul
complement
quickli
diminish
less
level
circul
adult
cow
day
age
level
complement
circul
gradual
increas
month
age
risen
approxim
level
adult
interferon
activ
epitheli
cell
neonat
appear
normal
product
type
interferon
leukocyt
lower
cellular
compon
innat
immun
also
affect
number
neutrophil
circul
newborn
calf
approxim
four
time
higher
calv
neonat
neutrophil
macrophag
reduc
phagocyt
abil
capac
increas
ingest
colostrum
week
age
neutrophil
function
abl
mount
effect
respons
neutrophil
function
gradual
improv
adult
level
month
age
number
dendrit
cell
lower
neonat
abil
present
antigen
activ
acquir
immun
system
limit
monocyt
migrat
tissu
develop
dendrit
cell
proinflammatori
stimul
number
circul
natur
killer
cell
also
lower
week
age
total
lymphocyt
adult
fraction
circul
natur
killer
cell
increas
week
age
neonat
calf
agammaglobulinem
depend
colostr
intak
immunoglobulin
number
circul
b
cell
greatli
reduc
neonat
repres
total
lymphocyt
week
age
compar
approxim
adult
fraction
b
cell
circul
increas
gradual
total
lymphocyt
week
age
low
number
b
cell
coupl
calv
endogen
corticosteroid
absorb
matern
hormon
result
prolong
lack
endogen
antibodi
respons
even
face
appar
cytokin
bia
neonat
endogen
product
igm
colostrumdepriv
calv
begin
appear
circul
day
birth
reach
expect
function
level
mgml
day
age
level
circul
iga
igg
igg
reach
appreci
level
day
birth
tcell
subset
adultlik
ratio
neonat
cell
repres
total
lymphocyt
helper
cell
approxim
cytotox
cell
approxim
gammadelta
cell
repres
approxim
total
lymphocyt
first
week
decreas
approxim
week
age
total
number
gammadelta
cell
circul
chang
fraction
circul
lymphocyt
decreas
percentag
b
cell
increas
total
number
cell
increas
mitogen
activ
lymphocyt
slightli
depress
birth
remain
constant
day
birth
certainli
one
major
challeng
develop
activ
immun
respons
young
calv
interfer
matern
immun
see
fig
problem
demonstr
sever
pathogen
includ
rotaviru
bvdv
bovin
respiratori
syncyti
viru
brsv
bovin
mannheimia
pasturella
haemolytica
time
mani
vaccin
administr
parenter
rout
involv
estim
level
matern
antibodi
low
enough
activ
immun
respons
progress
suffici
provid
vaccin
immun
see
fig
matern
antibodi
decay
halflif
day
prime
window
vaccin
anywher
week
month
illustr
fig
period
vari
anim
depend
level
matern
antibodi
vaccin
antigen
present
major
challeng
vaccin
develop
antibodi
level
often
decay
level
still
high
enough
block
respons
vaccin
high
enough
resist
field
infect
creat
window
opportun
infect
organ
virus
bvdv
month
age
often
good
time
administ
modifi
live
vaccin
mlv
parenter
vaccin
day
age
fourway
viral
mlv
follow
booster
month
age
result
anamnest
antibodi
respons
either
brsv
parenter
vaccin
either
inactiv
mlv
week
age
presenc
matern
antibodi
result
cellular
respons
mlv
group
increas
antibodi
titer
either
vaccin
revaccin
either
vaccin
month
later
result
anamnest
respons
antibodi
titer
indic
import
time
bacterin
period
matern
antibodi
interfer
usual
shorter
exampl
colostrumf
calv
vaccin
haemolytica
seroconvert
week
age
develop
protect
activ
brsv
immun
one
difficult
issu
calv
observ
matern
interfer
often
present
calv
develop
vaccin
plan
avoid
window
suscept
brsv
infect
import
difficult
goal
see
fig
problem
brsv
antibodi
decay
longd
approxim
daysdand
titer
low
interfer
mlv
brsv
parenter
vaccin
approach
use
vaccin
develop
overcom
matern
interfer
one
success
strategi
matern
antibodi
interfer
use
intranas
vaccin
brsv
young
calv
addit
experiment
studi
bvdv
calv
also
provid
protect
bvdv
challeng
experiment
live
pasturella
multicida
vaccin
also
develop
shown
induc
high
level
secretori
antibodi
vaccin
advantag
abl
replic
nasal
mucosa
prime
mucos
immun
system
littl
interfer
secretori
antibodi
mucos
immun
prime
vaccin
also
like
prevent
infect
rather
reduc
diseas
low
system
antibodi
titer
often
detect
vaccin
make
difficult
assess
immun
use
serolog
despit
lack
seroconvers
vaccin
gener
protect
immun
last
month
addit
advantag
vaccin
abil
induc
interferon
induc
antivir
state
within
hour
administr
induct
interferon
young
calv
also
may
aid
develop
matur
immun
system
anoth
approach
overcom
matern
immun
use
adjuv
parenter
vaccin
although
clear
adjuv
vaccin
overcom
matern
interfer
three
report
success
use
young
calv
avail
adjuv
inactiv
commerci
viral
vaccin
use
calv
protect
brsv
challeng
week
age
adjuv
viral
mlv
use
seroposit
calv
protect
virul
bvdv
challeng
month
age
inactiv
viral
vaccin
given
calv
prime
anim
revaccin
week
later
develop
memori
bvdv
antibodi
respons
experi
perform
mice
demonstr
potent
adjuv
break
bia
mice
sendai
viru
vaccin
adjuv
immunestimul
complex
stimul
immun
respons
promin
interferongamma
wherea
sendai
viru
vaccin
adjuv
tradit
al
oh
adjuv
produc
respons
particular
note
experi
adjuv
al
oh
capabl
produc
signific
antibodi
level
confin
nonmemori
subclass
date
two
experiment
vaccin
system
demonstr
abil
break
bia
young
livestock
small
dna
sequenc
call
oligodeoxynucleotid
contain
one
unmethyl
cpg
motif
cpg
odn
shown
potent
stimul
immun
respons
use
vaccin
adjuv
onedayold
piglet
vaccin
attenu
pseudorabi
viru
adjuv
system
contain
cpg
odn
induc
signific
cellular
prolifer
interferongamma
product
respons
vaccin
antigen
within
first
week
vaccin
vaccin
also
induc
signific
antibodi
titer
even
better
immun
respons
obtain
ad
plasmid
express
proinflammatori
porcin
cpg
odn
adjuv
prv
vaccin
neonat
calv
vaccin
subcutan
hour
birth
attenu
mycobacterium
bovi
bacillu
calmetteguerin
develop
effect
immun
calv
demonstr
strong
antigenspecif
interferongamma
respons
bovi
purifi
protein
deriv
upon
challeng
virul
bovi
week
age
calv
vaccin
bacillu
calmetteguerin
protect
develop
tubercul
lesion
wherea
unvaccin
control
develop
lesion
note
experi
none
calv
develop
signific
level
bovisspecif
antibodi
oneweekold
calv
vaccin
bacillu
calmetteguerin
also
gener
signific
cell
mediat
immun
fail
produc
signific
antibodi
respons
convers
young
adult
effect
produc
cellmedi
immun
respons
serum
antibodi
titer
takehom
messag
cellmedi
respons
vaccin
induc
earli
howev
anim
may
need
old
week
vaccin
induc
correspond
antibodi
respons
develop
day
vaccin
mani
vaccin
protocol
develop
vaccin
young
calv
frequenc
often
weekli
first
second
month
age
find
experiment
studi
support
frequenc
difficult
immun
system
clear
frequent
vaccin
young
anim
lead
antigenspecif
toler
ie
lack
immun
respons
antigen
result
suppress
cell
delet
b
clone
specif
antigen
anoth
possibl
advers
outcom
overvaccin
autoimmun
whose
develop
base
prime
anim
antigen
self
close
mimick
vaccin
antigen
anim
antigen
exampl
mimicri
antibodi
one
surfac
protein
infecti
bovin
rhinotrach
ibr
crossreact
surfac
protein
immun
cell
stimul
inflammatori
mechan
associ
vaccin
eg
adjuv
alum
microbi
ligand
repeat
reexposur
vaccin
compon
drive
expans
autoimmun
band
tcell
clone
may
occur
frequent
repeat
vaccin
stimul
anim
vaccin
expans
popul
respond
tand
bcell
clone
fig
requir
good
immun
respons
clonal
expans
stop
activ
process
cell
death
apoptosi
occur
see
fig
wane
process
allow
cull
b
cell
may
poor
respond
even
caus
autoimmun
remov
apoptosi
whole
process
vaccin
achiev
homeostasi
take
least
week
develop
primari
respons
boost
get
true
anamnest
secondari
respons
first
necess
plan
calf
vaccin
program
assess
diseas
risk
product
site
often
blanket
vaccin
program
suggest
mani
pathogen
may
may
threat
young
calf
health
one
must
care
review
antigen
use
make
sure
make
sens
oper
second
effect
matern
immun
age
calf
must
consid
relationship
linear
younger
calf
poorer
respons
older
calf
better
respons
invers
relationship
true
standpoint
protect
afford
matern
immun
younger
calf
better
protect
high
level
matern
antibodi
older
calf
suscept
diseas
wane
matern
antibodi
manag
factor
also
come
play
dairi
oper
isol
calv
exposur
pathogen
good
biosecur
provid
window
enhanc
protect
matern
immun
give
extend
window
vaccin
necessari
practic
feed
wast
milk
dairi
may
break
isol
introduc
pathogen
antibiot
alter
natur
flora
develop
calf
make
suscept
may
warrant
aggress
vaccin
program
activ
immun
brsv
probabl
difficult
matern
interfer
tabl
requir
care
monitor
frequent
revaccin
calv
protect
reach
window
suscept
time
frame
anim
longer
protect
passiv
immun
activ
immun
stimul
promis
develop
brsv
vaccin
licens
europ
vaccin
take
advantag
poor
penetr
antibodi
colostrum
onto
mucos
surfac
provid
less
interfer
function
vaccin
vaccin
reduc
clinic
diseas
colostrumf
calv
challeng
day
vaccin
anoth
studi
administ
commerci
fourway
viral
mlv
vaccin
licens
parenter
use
intranas
colostrumf
calv
found
protect
day
vaccin
singl
dose
inactiv
fourway
viral
vaccin
calv
protect
brsv
challeng
week
vaccin
risk
bvdv
infect
diseas
young
calv
seem
much
lower
brsv
addit
immunosuppress
calv
result
bvdv
compon
mani
parenter
administ
bvdv
mlv
deserv
consider
studi
conduct
calf
ranch
indic
littl
advantag
gain
vaccin
calv
younger
day
age
matern
antibodi
protect
last
day
greatest
risk
bvdv
infect
month
age
anim
group
hous
larger
group
vaccin
program
vaccin
calv
first
day
much
later
month
effect
prevent
infect
base
inform
bvdv
control
program
use
mlv
probabl
begin
around
month
age
follow
revaccin
week
infect
like
bvdv
unlik
young
calv
tabl
sever
posit
aspect
vaccin
matern
interfer
less
like
mucos
site
young
anim
develop
activ
immun
vaccin
high
level
mucos
serum
interferon
also
produc
direct
antivir
effect
may
aid
develop
neonat
immun
respons
also
immunosuppress
local
limit
replic
nasal
epithelium
howev
vaccin
less
danger
develop
immunosuppress
parenter
vaccin
vaccin
includ
vaccin
result
latenc
abil
viru
reactiv
recrudesc
shed
biolog
relev
reactiv
shed
unclear
lesion
diseas
syndrom
associ
recrudesc
viru
reactiv
experiment
sever
day
treatment
high
dose
dexamethason
multistrain
clostridium
spp
bacterintoxoid
frequent
part
vaccin
program
heifer
tabl
pathogen
repres
caus
sporad
enter
musculoskelet
diseas
local
vaccin
reaction
frequent
seriou
side
effect
matern
interfer
significantli
inhibit
clostridi
spp
antibodi
respons
calv
vaccin
day
age
bacteri
pathogen
frequent
isol
mani
case
calf
pneumonia
pose
signific
threat
heifer
develop
tabl
bacterintoxoid
avirul
mlv
commonli
use
bacterintoxoid
shown
inhibit
matern
transfer
immun
week
age
emerg
pathogen
also
frequent
isol
pneumonia
heifer
tabl
current
vaccin
common
use
bacterin
time
articl
singl
experiment
vaccin
administ
week
calv
low
bovi
antibodi
shown
protect
calv
challeng
day
later
although
salmonella
spp
import
pathogen
calv
welldesign
control
studi
literatur
field
observ
studi
salmonella
vaccin
efficaci
three
major
group
salmonella
vaccin
inactiv
gramneg
core
antigen
jvac
endovacbovi
attenu
live
vaccin
enterven
subunit
siderophor
receptor
protein
vaccin
tabl
three
vaccin
group
shown
efficaci
field
attenu
live
vaccin
label
use
calv
week
old
two
virus
common
caus
neonat
diarrhea
matern
antibodi
dramat
decreas
vaccin
efficaci
onset
protect
diseas
shed
calv
occur
secretori
iga
produc
day
vaccin
impli
oral
administ
vaccin
may
activ
innat
immun
system
gastrointestin
tract
decreas
diseas
vaccin
would
greatest
valu
herd
colostrum
low
level
rotaviru
coronaviru
antibodi
vaccin
heifer
calv
complic
presenc
signific
level
matern
antibodi
persist
calv
colostr
neonat
hormon
factor
lack
full
immun
compet
interfer
function
vaccin
presenc
matern
immun
first
necess
plan
calf
vaccin
program
assess
diseas
risk
product
site
one
must
care
review
antigen
use
make
sure
make
sens
oper
affect
matern
immun
age
anim
must
care
consid
determin
vaccin
schedul
use
mlvcontain
immunosuppress
agent
plan
avoid
give
time
anim
low
immunocompet
immunosuppress
use
mucos
vaccin
rout
minim
induc
immunosuppress
interfer
matern
antibodi
also
help
